Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial

Table 2 Association between imaging findings location with PSMA- and/or Choline-PET/CT and treatment decision. Salvage radiotherapy (sRT); Androgen deprivation therapy (ADT).

		Therapeutic decision
		sRT		ADT ± sRT
	Location	n/N	%	n/N	%	Odds Ratio (95% CI)	P-value¹
Molecular imaging findings	Extraprostatic Fossa Negative	6/13 6/10 40/50	46.2 60.0 80.0	7/13 4/10 10/50	53.8 40.0 20.0	4.67(1.28;16.99) 2.67(0.63;11.28)	0.0490*
	Positive Negative	12/23 40/50	52.2 80.0	11/23 10/50	47.8 20.0	3.67(1.25;10.71)	0.0175*
	Metastatic Non-metastatic	6/13 46/60	46.2 76.7	7/13 14/60	53.8 23.3	3.83(1.11;13.30)	0.0342*

¹Based on Bivariate Logistic Regression with Wald confidence interval, and Firth Correction for bias (C) when
appropriate. * <0.05

ISSN: 1470-7330